NIR spectroscopy is an effective way to determine muscle mass in the elderly, say Japanese medical researchers.
NIR News Blog
Posted: 10 October 2012
Specim, Spectral Imaging, Ltd, has released AisaFENIX, a robust and compact spectral imager for field and airborne installations.
Posted: 9 October 2012
The Fiji Sugar Corporation is to buy a NIR analyser to test all incoming sugar and pay farmers on the basis of its quality.
Posted: 8 October 2012
When the olive harvest in Spain and Portugal gets underway this November some forward-looking oil producers will have a NIR new tool to help them get the best from their olive presses.
Posted: 8 October 2012
The Korean National Agricultural Products Quality Management Service has purchased 49 units of the Foss Infratec 1241 near infrared grain analyser for rice labelling control.
Posted: 2 October 2012
NASA and the US Geological Survey provide data from their Landsat satellites for free. This data is already used by farmers to monitor nitrogen levels in their fields and plan fertiliser application.
Posted: 2 October 2012
Novel, biocompatible nanoparticles luminesce in the NIR through more than 3 cm of biological tissue, demonstrating the promise of nanotechnology in biomedical imaging.
Posted: 1 October 2012
The short course programme at Pittcon 2013 has been announced.
Posted: 1 October 2012
Optical coherence tomography (OCT) has been used to non-invasively map out the network of tiny blood vessels beneath the outer layer of patients’ skin, potentially revealing signs of disease. The researchers tested their system on a range of different skin conditions, including two cases of basal cell carcinoma. Compared to healthy skin, the network of vessels supplying blood to the tested lesions showed significantly altered patterns.
Posted: 27 September 2012
New optical imaging technology using NIR developed at Tufts University School of Engineering (Boston, MA, USA) could give doctors new ways to both identify breast cancer and monitor individual patients’ response to initial treatment of the disease. A five-year clinical study of the procedure, funded by a $3.5 million grant from the National Institutes of Health, is now underway at Tufts Medical Center.
Pages
